The evolution of treatment resistance: biologic implications.
about
Refractory schizophrenia and atypical antipsychoticsT102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variabilityLong-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia.Concept and Management of Treatment Resistant Schizophrenia (TRS)Medication options for treatment-resistant schizophrenia: implications for global mental health financing.Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia
P2860
Q22241831-BDF2DE86-A488-486F-B288-6F4A27502CCEQ33922225-FABA083D-0503-4C1B-A875-513539FBB3D0Q37278334-55698E40-DE07-4590-AC6F-748E3AA16454Q38774207-F9275FAA-8A8E-4614-8C05-0F059C478F45Q40521264-4C040F5A-D079-42E0-803A-FB64A0B1814FQ51922800-4B189B07-D773-435E-AA95-312A4304C79AQ57820263-ECE5DE1F-F55E-4D18-92CA-82D09AFEE934
P2860
The evolution of treatment resistance: biologic implications.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
The evolution of treatment resistance: biologic implications.
@en
type
label
The evolution of treatment resistance: biologic implications.
@en
prefLabel
The evolution of treatment resistance: biologic implications.
@en
P2093
P1476
The evolution of treatment resistance: biologic implications.
@en
P2093
P304
P356
10.1097/00004714-199804001-00003
P407
P433
P577
1998-04-01T00:00:00Z